234 related articles for article (PubMed ID: 17659823)
1. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.
Grenyer BF; Crowe T; Meyer B; Owen AJ; Grigonis-Deane EM; Caputi P; Howe PR
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1393-6. PubMed ID: 17659823
[TBL] [Abstract][Full Text] [Related]
2. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
3. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.
Silvers KM; Woolley CC; Hamilton FC; Watts PM; Watson RA
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):211-8. PubMed ID: 15664306
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.
Rees AM; Austin MP; Parker GB
Aust N Z J Psychiatry; 2008 Mar; 42(3):199-205. PubMed ID: 18247194
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acids in major depressive disorder.
Freeman MP
J Clin Psychiatry; 2009; 70 Suppl 5():7-11. PubMed ID: 19909687
[TBL] [Abstract][Full Text] [Related]
6. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
8. Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?
de Fijter CW; Popp-Snijders C; Oe LP; Tran DD; van der Meulen J; Donker AJ
Haematologica; 1995; 80(4):332-4. PubMed ID: 7590502
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
Lespérance F; Frasure-Smith N; St-André E; Turecki G; Lespérance P; Wisniewski SR
J Clin Psychiatry; 2011 Aug; 72(8):1054-62. PubMed ID: 20584525
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of omega-3 fatty acid supplements in perinatal women.
Freeman MP; Sinha P
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):203-8. PubMed ID: 17981449
[TBL] [Abstract][Full Text] [Related]
13. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I
Nutrition; 2005 Feb; 21(2):131-6. PubMed ID: 15723739
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study.
Bot M; Pouwer F; Assies J; Jansen EH; Diamant M; Snoek FJ; Beekman AT; de Jonge P
J Affect Disord; 2010 Oct; 126(1-2):282-6. PubMed ID: 20466431
[TBL] [Abstract][Full Text] [Related]
15. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
16. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
[TBL] [Abstract][Full Text] [Related]
17. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
19. [Active rheumatoid arthritis: effect of dietary supplementation with omega-3 oils. A controlled double-blind trial].
Astorga G; Cubillos A; Masson L; Silva JJ
Rev Med Chil; 1991 Mar; 119(3):267-72. PubMed ID: 1842119
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
